Phio Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

          Phio Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment ConferenceSeptember 03, 2025 7:45 AM EDT | Source: Phio Pharmaceuticals Corp.Clinical trial advances to anticipated final cohort for INSTASYL siRNA lead product candidate PH-7625th cohort patients now being treated in on-going clinical studyKing of Prussia, Pennsylvania--(Newsfile Corp. - September 3, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing the ...